Senesco Technologies Inc. (ELOX) Expected to Announce Earnings of -$0.39 Per Share

Equities research analysts predict that Senesco Technologies Inc. (NYSE:ELOX) will report earnings per share of ($0.39) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Senesco Technologies’ earnings, with the highest EPS estimate coming in at ($0.33) and the lowest estimate coming in at ($0.48). Senesco Technologies posted earnings of ($0.23) per share during the same quarter last year, which would indicate a negative year over year growth rate of 69.6%. The business is scheduled to announce its next earnings report on Tuesday, August 6th.

On average, analysts expect that Senesco Technologies will report full-year earnings of ($1.57) per share for the current financial year, with EPS estimates ranging from ($1.93) to ($1.32). For the next year, analysts forecast that the firm will post earnings of ($1.60) per share, with EPS estimates ranging from ($1.76) to ($1.36). Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Senesco Technologies.

Senesco Technologies (NYSE:ELOX) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.33) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.08.

Senesco Technologies stock opened at $11.08 on Monday. Senesco Technologies has a 1-year low of $9.12 and a 1-year high of $24.60.

Senesco Technologies Company Profile

Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.

Featured Story: What Does a Sell-Side Analyst Rating Mean?

Get a free copy of the Zacks research report on Senesco Technologies (ELOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit